Atherogenics, Inc. (AGIX)

Atherogenics, Inc. is related to 5 other symbols. To date we've encountered 101 releases involving Atherogenics, Inc..

Last Price: 0.07 (0.00) - 10/13/2008, 3:00pm

• Open: N/A
• High: N/A
• Low: N/A

Atherogenics, Inc. Options

• Atherogenics, Inc. "Business Partners"
• Atherogenics, Inc. Press Releases
• Atherogenics, Inc. News
• Atherogenics, Inc. Contact
• Atherogenics, Inc. Related (via TRYNT)

Atherogenics, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Atherogenics, Inc..

• IMGG
• MIOK
• NCII
• TIE
• WEW

^

Atherogenics, Inc. Press Releases

• AtheroGenics: AtheroGenics Reports Third Quarter 2006 Financial Results (Trackbacks) (Backlinks), Tue, 24 Oct 2006 4:00:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results for the third quarter and nine months ended September 30, 2006.

• AtheroGenics: AtheroGenics to Webcast Third Quarter Results Conference Call on October 24, 2006 (Trackbacks) (Backlinks), Thu, 12 Oct 2006 4:00:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it expects to release its third quarter 2006 results of operations on Tuesday, October 24, 2006, before the U.S. financial markets open.

• AtheroGenics: AtheroGenics to Present at the A.G. Edwards Emerging Growth Conference on September 20, 2006 (Trackbacks) (Backlinks), Thu, 14 Sep 2006 5:00:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the A.G. Edwards Emerging Growth Conference on Wednesday, September 20, 2006, at 8:30 a.m. ET at The New York Palace Hotel in New York, NY.

• AtheroGenics, Inc.: AtheroGenics to Present at Thomas Weisel Partners' Healthcare Conference on September 6, 2006 (Trackbacks) (Backlinks), Tue, 29 Aug 2006 5:14:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 6, 2006, at 1:30 p.m. EDT at The Four Seasons Hotel in Boston, Massachusetts.

• AtheroGenics, Inc.: AtheroGenics, Inc. Announces Two New Board Members (Trackbacks) (Backlinks), Tue, 18 Jul 2006 7:44:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the election of two new members to its Board of Directors: Sam L. Barker, Ph.D., a founder of Clearview Projects, Inc. and former pharmaceutical industry executive at Bristol-Myers Squibb; and Margaret E. Grayson, President of AEP Government Solutions Group and

• AtheroGenics, Inc.: AtheroGenics to Webcast Second Quarter Results Conference Call on July 20, 2006 (Trackbacks) (Backlinks), Thu, 6 Jul 2006 12:11:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it expects to release its second quarter 2006 results of operations on Thursday, July 20, 2006, before the U.S. financial markets open.

• AtheroGenics: AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President (Trackbacks) (Backlinks), Thu, 6 Jul 2006 6:41:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the promotion of Joseph M. Gaynor, Jr. to Senior Vice President and General Counsel.

• AtheroGenics: AtheroGenics to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference on June 14, 2006 (Trackbacks) (Backlinks), Thu, 8 Jun 2006 7:45:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference on Wednesday, June 14, 2006, at 4:30 p.m. EDT at The

• AtheroGenics: AtheroGenics Announces Promotions of Three Senior Executives (Trackbacks) (Backlinks), Thu, 11 May 2006 6:45:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the promotion of Mark P. Colonnese to Executive Vice President, Commercial Operations; Rob Scott, M.D. to Executive Vice President, Research and Development; and W. Charles Montgomery, Ph.D. to Senior Vice President, Business Development and Alliance Management. Mr.

• AtheroGenics: AtheroGenics to Present at Morgan Stanley Global Healthcare Unplugged Conference on May 3, 2006 (Trackbacks) (Backlinks), Fri, 28 Apr 2006 6:31:00 PDT

  ATLANTA, GA (MARKET WIRE) AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, and Rob Scott, M.D., Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer, are scheduled to present a company overview and update at the Morgan Stanley

^

Atherogenics, Inc. News

• We have not detected any news yet.

^

Atherogenics, Inc. Contact

• Corporate Communications
  Donna L. Glasky
  AtheroGenics, Inc.
  678-336-2517
  Email Contact
  
  Media Relations
  Jayme Maniatis
  Vice President
  Schwartz Communications, Inc.
  781-684-0770
  Email Contact
  
  

TRYNT Related

• Atherogenics (AGIX.MX)
• Lehman Yeelds Agix (LBHYI.PK)

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.